C Bourgault

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension
    C Bourgault
    Department of Epidemiology and Biostastics, Royal Victoria Hospital, McGill University Health Centre (MUHC, 687 Pine Ave W, Ross 4.29, Montreal, Quebec, Canada H3A 1A1
    Arch Intern Med 161:1873-9. 2001
  2. ncbi Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study
    C Bourgault
    Health Economics and Outcomes Research, Merck Frosst Canada Ltd, 16 711 TransCanada Highway, Kirkland, Quebec, Canada H9H 3L1
    J Hum Hypertens 19:607-13. 2005
  3. ncbi Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO)
    C Bourgault
    McGill University, Montreal, Canada
    Can J Cardiol 21:1187-93. 2005
  4. ncbi Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use
    C Bourgault
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    Pharmacoepidemiol Drug Saf 10:287-94. 2001

Detail Information

Publications4

  1. ncbi Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension
    C Bourgault
    Department of Epidemiology and Biostastics, Royal Victoria Hospital, McGill University Health Centre (MUHC, 687 Pine Ave W, Ross 4.29, Montreal, Quebec, Canada H3A 1A1
    Arch Intern Med 161:1873-9. 2001
    ..In addition, initial drug use does not seem to be in accordance with the stepped-care approach to hypertension therapy recommended in the Canadian guidelines...
  2. ncbi Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study
    C Bourgault
    Health Economics and Outcomes Research, Merck Frosst Canada Ltd, 16 711 TransCanada Highway, Kirkland, Quebec, Canada H9H 3L1
    J Hum Hypertens 19:607-13. 2005
    ..Further studies are required that relate intermittent treatment behaviours to health outcomes and costs in hypertension...
  3. ncbi Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO)
    C Bourgault
    McGill University, Montreal, Canada
    Can J Cardiol 21:1187-93. 2005
    ..Although statins are widely used to reduce low density lipoprotein cholesterol (LDL-C), there is little information about patient profiles, treatment patterns and goal achievement among statin-treated patients in Canada...
  4. ncbi Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use
    C Bourgault
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    Pharmacoepidemiol Drug Saf 10:287-94. 2001
    ..In addition, the estimates significantly varied across drug history profiles thus suggesting the presence of preferential prescribing of specific drug classes to high-risk patients...